PRESS RELEASE published on 06/30/2025 at 15:00, 1 year 1 month ago Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient Initial proof-of-concept results show crofelemer's efficacy in reducing TPN for intestinal failure patients. Jaguar seeking partnerships for drug development and commercialization Crofelemer Drug Development Jaguar Health TPN Reduction Intestinal Failure
BRIEF published on 06/30/2025 at 14:29, 1 year 1 month ago Jaguar Health: FDA Dialogue and Strategic Trials Crofelemer Clinical Trials Jaguar Health Breast Cancer FDA Meeting
BRIEF published on 06/30/2025 at 14:29, 1 year 1 month ago Jaguar Health : Dialogue avec la FDA et essais stratégiques Crofelemer Jaguar Health Essais Cliniques Cancer Du Sein Réunion De La FDA
PRESS RELEASE published on 06/30/2025 at 14:24, 1 year 1 month ago Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Buy recommendation on Jaguar Health Inc (ISIN: US47010C8055) to USD 40 target price post-positive breast cancer trial subgroup results. Plans for FDA approval through pivotal trial and orphan drug designation Jaguar Health Inc FDA Approval First Berlin Equity Research Orphan Drug Designation Pivotal Trial
BRIEF published on 06/26/2025 at 15:05, 1 year 1 month ago Jaguar Health va intégrer la cryptomonnaie dans ses réserves de trésorerie Jaguar Health Actifs Numériques Crypto-monnaie Réserve Du Trésor Programmes Crofelemer
BRIEF published on 06/26/2025 at 15:05, 1 year 1 month ago Jaguar Health to Incorporate Cryptocurrency into Treasury Reserves Digital Assets Jaguar Health Cryptocurrency Treasury Reserve Crofelemer Programs
PRESS RELEASE published on 06/26/2025 at 15:00, 1 year 1 month ago Jaguar Health Board of Directors Authorizes Company to Include Cryptocurrency as a Treasury Reserve Asset Jaguar Health, Inc. diversifies treasury holdings with long-term digital store of value through including cryptocurrency as a reserve asset. Company aims to safeguard against inflation and assesses potential benefits for core development programs Inflation Jaguar Health Cryptocurrency Treasury Reserve Asset Digital Store Of Value
BRIEF published on 06/25/2025 at 15:05, 1 year 1 month ago Jaguar Health demande l'approbation de l'UE pour Canalevia pour le traitement de la diarrhée canine Jaguar Health Union Européenne Médecine Vétérinaire Diarrhée Du Chien Canalevia
BRIEF published on 06/25/2025 at 15:05, 1 year 1 month ago Jaguar Health Seeks EU Approval for Canalevia to Treat Canine Diarrhea Veterinary Medicine Jaguar Health European Union Dog Diarrhea Canalevia
PRESS RELEASE published on 06/25/2025 at 15:00, 1 year 1 month ago Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs Jaguar Health plans to seek approval from the EU for Canalevia to treat general diarrhea in dogs. The drug is already FDA-approved for chemotherapy-induced diarrhea in dogs Jaguar Health EU Approval Diarrhea Treatment Canalevia Dog Healthcare
Published on 08/13/2026 at 09:05, 2 hours 26 minutes ago Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
Published on 08/13/2026 at 08:00, 3 hours 31 minutes ago Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
Published on 08/13/2026 at 07:30, 4 hours 1 minute ago Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
Published on 08/12/2026 at 23:30, 12 hours 1 minute ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/13/2026 at 11:10, 21 minutes ago Omio expands global ground transport network with Greyhound Australia partnership
Published on 08/13/2026 at 11:05, 26 minutes ago BIRKENSTOCK REPORTS FISCAL THIRD QUARTER 2026 RESULTS WITH 15% CONSTANT F/X REVENUE GROWTH LED BY DTC; RAISES GUIDANCE FOR FY26
Published on 08/13/2026 at 11:00, 31 minutes ago ABB Ltd: ABB share buybacks - August 6, 2026 - August 12, 2026
Published on 08/13/2026 at 10:13, 1 hour 18 minutes ago Turkiye Garanti Bankasi A.S.: Issuance of Green/Sustainable Eurobond
Published on 08/11/2026 at 17:45, 1 day 17 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 17 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 17 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 17 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026